Click for best price
Neuropathic Pain Drugs Market Size, Share 2023
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
This report aims to provide a comprehensive presentation of the global market for Neuropathic Pain Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Pain Drugs. This report contains market size and forecasts of Neuropathic Pain Drugs in global, including the following market information:
Global Neuropathic Pain Drugs Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Neuropathic Pain Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.
We surveyed the Neuropathic Pain Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuropathic Pain Drugs Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Neuropathic Pain Drugs Market Segment Percentages, by Type, 2022 (%)
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Global Neuropathic Pain Drugs Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Neuropathic Pain Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Neuropathic Pain Drugs Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Neuropathic Pain Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuropathic Pain Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neuropathic Pain Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neuropathic Pain Drugs, market overview.
Chapter 2: Global Neuropathic Pain Drugs market size in revenue.
Chapter 3: Detailed analysis of Neuropathic Pain Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neuropathic Pain Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Neuropathic Pain Drugs Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neuropathic Pain Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuropathic Pain Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuropathic Pain Drugs Overall Market Size
2.1 Global Neuropathic Pain Drugs Market Size: 2022 VS 2035
2.2 Global Neuropathic Pain Drugs Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuropathic Pain Drugs Players in Global Market
3.2 Top Global Neuropathic Pain Drugs Companies Ranked by Revenue
3.3 Global Neuropathic Pain Drugs Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Pain Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuropathic Pain Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Pain Drugs Players in Global Market
3.6.1 List of Global Tier 1 Neuropathic Pain Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Pain Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuropathic Pain Drugs Market Size Markets, 2022 & 2035
4.1.2 Tricyclic Anti-Depressants Anticonvulsants
4.1.3 Serotonin-Norepinephrine Reuptake Inhibitor
4.1.4 Capsaicin Cream
4.1.5 Local Anaesthesia
4.1.6 Opioids
4.1.7 Steroids
4.1.8 Others
4.2 By Type - Global Neuropathic Pain Drugs Revenue & Forecasts
4.2.1 By Type - Global Neuropathic Pain Drugs Revenue, 2018-2023
4.2.2 By Type - Global Neuropathic Pain Drugs Revenue, 2024-2035
4.2.3 By Type - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuropathic Pain Drugs Market Size, 2022 & 2035
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Neuropathic Pain Drugs Revenue & Forecasts
5.2.1 By Application - Global Neuropathic Pain Drugs Revenue, 2018-2023
5.2.2 By Application - Global Neuropathic Pain Drugs Revenue, 2024-2035
5.2.3 By Application - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Neuropathic Pain Drugs Market Size, 2022 & 2035
6.2 By Region - Global Neuropathic Pain Drugs Revenue & Forecasts
6.2.1 By Region - Global Neuropathic Pain Drugs Revenue, 2018-2023
6.2.2 By Region - Global Neuropathic Pain Drugs Revenue, 2024-2035
6.2.3 By Region - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Neuropathic Pain Drugs Revenue, 2018-2035
6.3.2 US Neuropathic Pain Drugs Market Size, 2018-2035
6.3.3 Canada Neuropathic Pain Drugs Market Size, 2018-2035
6.3.4 Mexico Neuropathic Pain Drugs Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Neuropathic Pain Drugs Revenue, 2018-2035
6.4.2 Germany Neuropathic Pain Drugs Market Size, 2018-2035
6.4.3 France Neuropathic Pain Drugs Market Size, 2018-2035
6.4.4 U.K. Neuropathic Pain Drugs Market Size, 2018-2035
6.4.5 Italy Neuropathic Pain Drugs Market Size, 2018-2035
6.4.6 Russia Neuropathic Pain Drugs Market Size, 2018-2035
6.4.7 Nordic Countries Neuropathic Pain Drugs Market Size, 2018-2035
6.4.8 Benelux Neuropathic Pain Drugs Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Neuropathic Pain Drugs Revenue, 2018-2035
6.5.2 China Neuropathic Pain Drugs Market Size, 2018-2035
6.5.3 Japan Neuropathic Pain Drugs Market Size, 2018-2035
6.5.4 South Korea Neuropathic Pain Drugs Market Size, 2018-2035
6.5.5 Southeast Asia Neuropathic Pain Drugs Market Size, 2018-2035
6.5.6 India Neuropathic Pain Drugs Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Neuropathic Pain Drugs Revenue, 2018-2035
6.6.2 Brazil Neuropathic Pain Drugs Market Size, 2018-2035
6.6.3 Argentina Neuropathic Pain Drugs Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuropathic Pain Drugs Revenue, 2018-2035
6.7.2 Turkey Neuropathic Pain Drugs Market Size, 2018-2035
6.7.3 Israel Neuropathic Pain Drugs Market Size, 2018-2035
6.7.4 Saudi Arabia Neuropathic Pain Drugs Market Size, 2018-2035
6.7.5 UAE Neuropathic Pain Drugs Market Size, 2018-2035
7 Neuropathic Pain Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neuropathic Pain Drugs Major Product Offerings
7.1.4 Pfizer Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Neuropathic Pain Drugs Major Product Offerings
7.2.4 Johnson & Johnson Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Neuropathic Pain Drugs Major Product Offerings
7.3.4 Sanofi Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Neuropathic Pain Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Neuropathic Pain Drugs Major Product Offerings
7.5.4 Eli Lilly Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Biogen
7.7.1 Biogen Company Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Neuropathic Pain Drugs Major Product Offerings
7.7.4 Biogen Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.7.5 Biogen Key News & Latest Developments
7.8 Baxter Healthcare
7.8.1 Baxter Healthcare Company Summary
7.8.2 Baxter Healthcare Business Overview
7.8.3 Baxter Healthcare Neuropathic Pain Drugs Major Product Offerings
7.8.4 Baxter Healthcare Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.8.5 Baxter Healthcare Key News & Latest Developments
7.9 Depomed
7.9.1 Depomed Company Summary
7.9.2 Depomed Business Overview
7.9.3 Depomed Neuropathic Pain Drugs Major Product Offerings
7.9.4 Depomed Neuropathic Pain Drugs Revenue in Global Market (2018-2023)
7.9.5 Depomed Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Neuropathic Pain Drugs Market Opportunities & Trends in Global Market
Table 2. Neuropathic Pain Drugs Market Drivers in Global Market
Table 3. Neuropathic Pain Drugs Market Restraints in Global Market
Table 4. Key Players of Neuropathic Pain Drugs in Global Market
Table 5. Top Neuropathic Pain Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Neuropathic Pain Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Neuropathic Pain Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Neuropathic Pain Drugs Product Type
Table 9. List of Global Tier 1 Neuropathic Pain Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuropathic Pain Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Neuropathic Pain Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Neuropathic Pain Drugs Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Neuropathic Pain Drugs Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Neuropathic Pain Drugs Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Neuropathic Pain Drugs Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Neuropathic Pain Drugs Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Neuropathic Pain Drugs Revenue, (US$, Mn), 2024-2035
Table 30. Pfizer Company Summary
Table 31. Pfizer Neuropathic Pain Drugs Product Offerings
Table 32. Pfizer Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Neuropathic Pain Drugs Product Offerings
Table 36. Johnson & Johnson Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Neuropathic Pain Drugs Product Offerings
Table 40. Sanofi Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Neuropathic Pain Drugs Product Offerings
Table 44. GlaxoSmithKline Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Neuropathic Pain Drugs Product Offerings
Table 48. Eli Lilly Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Neuropathic Pain Drugs Product Offerings
Table 52. Bristol-Myers Squibb Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Biogen Company Summary
Table 55. Biogen Neuropathic Pain Drugs Product Offerings
Table 56. Biogen Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Biogen Key News & Latest Developments
Table 58. Baxter Healthcare Company Summary
Table 59. Baxter Healthcare Neuropathic Pain Drugs Product Offerings
Table 60. Baxter Healthcare Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Baxter Healthcare Key News & Latest Developments
Table 62. Depomed Company Summary
Table 63. Depomed Neuropathic Pain Drugs Product Offerings
Table 64. Depomed Neuropathic Pain Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Depomed Key News & Latest Developments
List of Figures
Figure 1. Neuropathic Pain Drugs Segment by Type in 2022
Figure 2. Neuropathic Pain Drugs Segment by Application in 2022
Figure 3. Global Neuropathic Pain Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neuropathic Pain Drugs Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Neuropathic Pain Drugs Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuropathic Pain Drugs Revenue in 2022
Figure 8. By Type - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 9. By Application - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 10. By Type - Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 12. By Application - Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 14. By Region - Global Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 15. By Country - North America Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 16. US Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 20. Germany Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 21. France Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 28. China Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 32. India Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 34. Brazil Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Neuropathic Pain Drugs Revenue Market Share, 2018-2035
Figure 37. Turkey Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Neuropathic Pain Drugs Revenue, (US$, Mn), 2018-2035
Figure 41. Pfizer Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biogen Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Baxter Healthcare Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Depomed Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
